Next Article in Journal
Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1–2 Clinical Trial
Previous Article in Journal
Immunogenicity and Neutralization of Recombinant Vaccine Candidates Expressing F and G Glycoproteins against Nipah Virus
 
 
Review

Article Versions Notes

Vaccines 2024, 12(9), 1000; https://doi.org/10.3390/vaccines12091000 (registering DOI)
Action Date Notes Link
article xml file uploaded 1 September 2024 03:44 CEST Original file -
article xml uploaded. 1 September 2024 03:44 CEST Update -
article pdf uploaded. 1 September 2024 03:44 CEST Version of Record -
article html file updated 1 September 2024 03:47 CEST Original file -
article xml file uploaded 1 September 2024 12:36 CEST Update -
article xml uploaded. 1 September 2024 12:36 CEST Update -
article pdf uploaded. 1 September 2024 12:36 CEST Updated version of record -
article html file updated 1 September 2024 12:38 CEST Update -
article xml file uploaded 1 September 2024 12:47 CEST Update -
article xml uploaded. 1 September 2024 12:47 CEST Update https://www.mdpi.com/2076-393X/12/9/1000/xml
article pdf uploaded. 1 September 2024 12:47 CEST Updated version of record https://www.mdpi.com/2076-393X/12/9/1000/pdf
article html file updated 1 September 2024 12:48 CEST Update https://www.mdpi.com/2076-393X/12/9/1000/html
Back to TopTop